You are here

Algernon Pharmaceuticals Inc. - Warrants

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
AGN.WT
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough.

Algernon Pharmaceuticals Inc. - Common Shares

You are here

Algernon Pharmaceuticals Inc. - Warrants (AGN.WT)

SEDAR Information

Company Info

Address
Suite 900 - 700 West Pender Street
Vancouver, BC V6C 1G8
Canada
Phone
604-398-4175
Ext
701
Email
[email protected]
Website
https://algernonpharmaceuticals.com
Listing date
Monday, November 4, 2019
Transfer Agent
AST Trust Company (Canada)

Capitalization

Issued & Outstanding: 
24401300
Reserved for Issuance: 
0

News Releases

Bulletins

21/04/2023

2023-0422 - Expiry - Algernon Pharmaceuticals Inc. - Rights (AGN.RT)

le 21 avril/April 2023

Algernon Pharmaceuticals Inc. Rights listed on March 28, 2023 will expire on April 27, 2023.

Settlement Terms: All trades April 25 and 26 will be for cash next day settlement. Trades on April 27 will be for cash same day.

The rights will be halted at noon and delisted at market close April 27, 2023.

___________________________

CSE Filings